These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20368400)

  • 1. Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
    Hafner V; Czock D; Burhenne J; Riedel KD; Bommer J; Mikus G; Machleidt C; Weinreich T; Haefeli WE
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2596-602. PubMed ID: 20368400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
    Luke DR; Wood ND; Tomaszewski KE; Damle B
    Nephrol Dial Transplant; 2012 Mar; 27(3):1207-12. PubMed ID: 21868395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Kiser TH; Fish DN; Aquilante CL; Rower JE; Wempe MF; MacLaren R; Teitelbaum I
    Crit Care; 2015 Feb; 19(1):32. PubMed ID: 25645660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.
    Abel S; Allan R; Gandelman K; Tomaszewski K; Webb DJ; Wood ND
    Clin Drug Investig; 2008; 28(7):409-20. PubMed ID: 18544001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.
    Hoover RK; Alcorn H; Lawrence L; Paulson SK; Quintas M; Luke DR; Cammarata SK
    J Clin Pharmacol; 2018 Jun; 58(6):814-822. PubMed ID: 29578585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
    Luke DR; Tomaszewski K; Damle B; Schlamm HT
    J Pharm Sci; 2010 Aug; 99(8):3291-301. PubMed ID: 20213839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients.
    Peng LW; Lien YH
    Am J Kidney Dis; 2005 Jan; 45(1):162-6. PubMed ID: 15696456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intravenous voriconazole in patients with compromised renal function.
    Lilly CM; Welch VL; Mayer T; Ranauro P; Meisner J; Luke DR
    BMC Infect Dis; 2013 Jan; 13():14. PubMed ID: 23320795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.
    Scholz I; Oberwittler H; Riedel KD; Burhenne J; Weiss J; Haefeli WE; Mikus G
    Br J Clin Pharmacol; 2009 Dec; 68(6):906-15. PubMed ID: 20002085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
    Purkins L; Wood N; Greenhalgh K; Eve MD; Oliver SD; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):2-9. PubMed ID: 14616407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
    Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T
    J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
    von Mach MA; Burhenne J; Weilemann LS
    BMC Clin Pharmacol; 2006 Sep; 6():6. PubMed ID: 16981986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Cumulative Intravenous Voriconazole Dose on Renal Function in Hematological Patients.
    Yasu T; Konuma T; Kuroda S; Takahashi S; Tojo A
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kolliphor® HS 15-cyclodextrin Complex for the Delivery of Voriconazole: Preparation, Characterization, and Antifungal Activity.
    Li Y; Zhu C; Wu H; Pan H; Liu H
    Curr Drug Metab; 2020; 21(5):379-389. PubMed ID: 32432999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole injection may induce delayed methotrexate excretion: a case report and experimental study.
    Watahiki D; Saito D; Nishida N; Tsuri H; Nomura K; Adachi Y; Taguchi M
    J Pharm Health Care Sci; 2022 Mar; 8(1):9. PubMed ID: 35351207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
    Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ
    Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
    Pascual A; Csajka C; Buclin T; Bolay S; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2012 Aug; 55(3):381-90. PubMed ID: 22610925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
    Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.